← Evidence map

ArticleFrontiers in neuroimaging2026

Gadolinium-based contrast agent-free (GBCA-free) versus gadolinium-based contrast agent-enhanced (GBCA-enhanced) magnetic resonance imaging as a screening tool for intracranial tumors.

Haider Faeq Hadhratee Al-Rubaiee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Gadolinium-based contrast agent-free (GBCA-free) versus gadolinium-based contrast agent-enhanced (GBCA-enhanced) magnetic resonance imaging as a screening tool for intracranial tumors. | OpenQuestion